Neosil

US-based dermatology-focused specialty pharma, acquired by Peplin

placePalo Alto, California, United States calendar_todayFounded 2003 language neosil.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 23 times.

YearFilings
20221

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon